Prognostic value of bone marrow MUC4 expression in acute myeloid leukaemia

References

• Prada-Arismendy J, Arroyave JC, Rothlisberger S. Molecular biomarkers in acute myeloid leukemia. Blood Rev. 2017;31:63–76.
   PubMed Web of Science ®Google Scholar
• Estey E, Döhner H. Acute myeloid leukemia. Lancet. 2006;368:1894–1907.
   PubMed Web of Science ®Google Scholar
• Breems DA, Van Putten WL, Huijgens PC, et al. Prognostic index for adult patients with acute myeloid leukemia in first relapse. J Clin Oncol. 2005;23:1969–1978.
   PubMed Web of Science ®Google Scholar
• Jonckheere N, Van Seuningen I. The membrane- bound mucins: from cell signaling to transcriptional regulation and expression in epithelial cancers. Biochimie. 2010;92:1–11.
   PubMed Web of Science ®Google Scholar
• Pelaseyed T, Bergström JH, Gustafsson JK, et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev. 2014;260:8–20.
   PubMed Web of Science ®Google Scholar
• Kufe DW. Mucins in cancer: function, prognosis, and therapy. Nat Rev Cancer. 2009;9:874–885.
   PubMed Web of Science ®Google Scholar
• Moniaux N, Escande F, Porchet N, et al. Structural organization and classification of the human mucin genes. Front Biosci. 2001;6:D1192– D1206.
   PubMed Web of Science ®Google Scholar
• Andrianifahanana M, Moniaux N, Batra SK. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim Biophys Acta. 2006;1765:189–222.
   PubMed Web of Science ®Google Scholar
• Byrd JC, Bresalier RS. Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 2004;23:77–99.
   PubMed Web of Science ®Google Scholar
• Singh PK, Hollingsworth MA. Cell surface associated mucins in signal transduction. Trends Cell Biol. 2006;16:467–476.
   PubMed Web of Science ®Google Scholar
• Jonckheere N, Skrypek N, Merlin J, et al. The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways. PLoS One. 2012;7:e32232.
   PubMed Web of Science ®Google Scholar
• Karg A, Dinc ZA, Basok O, et al. MUC4 expression and its relation to ErbB2 expression, apoptosis, proliferation, differentiation, and tumor stage in non-small cell lung cancer (NSCLC). Pathol Res Pract. 2006;202:577.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Lakshmanan I, Ponnusamy MP, et al. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells. PLoS One. 2013;8:e54455.
   PubMed Web of Science ®Google Scholar
• Saitou M, Goto M, Horinouchi M, et al. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol. 2005;58:845–852.
   PubMed Web of Science ®Google Scholar
• Singh AP, Chauhan SC, Bafna S, et al. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas. Prostate. 2006;66:421–429.
   PubMed Web of Science ®Google Scholar
• Kaur S, Momi N, Chakraborty S, et al. Altered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis. PLoS One. 2014;9:e92742.
   PubMed Web of Science ®Google Scholar
• Tsutsumida H, Goto M, Kitajima S, et al. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer. 2007;55:195–203.
   PubMed Web of Science ®Google Scholar
• Chauhan SC, Singh AP, Ruiz F, et al. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol. 2006;19:1386–1394.
   PubMed Web of Science ®Google Scholar
• Alos L, Lujan B, Castillo M, et al. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol. 2005;29:806–813.
   PubMed Web of Science ®Google Scholar
• Heo SG, Hong EP, Park JW. Genetic risk prediction for normal-karyotype acute myeloid leukemia using whole-exome sequencing. Genomics Inform. 2013;11:46–51.
   PubMedGoogle Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C (T)) Method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Yonezawa S, Higashi M, Yamada N, et al. Mucins in human neoplasms: clinical pathology, gene expression and diagnostic application. Pathol Int. 2011;61:697–716.
   PubMed Web of Science ®Google Scholar
• Sadras T, Heatley SL, Kok CH, et al. Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions. Cancer Lett. 2017;408:92–110.
   PubMed Web of Science ®Google Scholar
• Jonckheere N, Seuningen IV. Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas. J Transl Med. 2018;16:259.
   PubMed Web of Science ®Google Scholar
• Andrianifahanana M, Singh AP, Nemos C, et al. IFN-gamma-induced expression of MUC4 in pancreatic cancer cells is mediated by STAT-1 up regulation: a novel mechanism for IFN-gamma response. Oncogene. 2007;26:7251–7261.
   PubMed Web of Science ®Google Scholar
• Jonckheere N, Perrais M, Mariette C, et al. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF beta in pancreatic carcinogenesis. Oncogene. 2004;23:5729–5738.
   PubMed Web of Science ®Google Scholar
• Yamada N, Nishida Y, Tsutsumida H, et al. Promoter CpG methylation in cancer cells contributes to the regulation of MUC4. Br J Cancer. 2009;100:344–351.
   PubMed Web of Science ®Google Scholar
• Lahdaoui F, Delpu Y, Vincent A, et al. miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer. Oncogene. 2015;34:780–788.
   PubMed Web of Science ®Google Scholar
• Mejías-Luque R, Peiró S, Vincent A, et al. IL-6 induces MUC4 expression through gp130/STAT3 pathway in gastric cancer cell lines. Biochim Biophys Acta. 2008;1783:1728–1736.
   PubMed Web of Science ®Google Scholar
• Stevens AM, Miller JM, Munoz JO, et al. Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance. Blood Adv. 2017;1:1387–1397.
   PubMed Web of Science ®Google Scholar
• Sanchez-Correa B, Bergua JM, Campos C, et al. Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels. Cytokine. 2013;61:885–891.
   PubMed Web of Science ®Google Scholar
• Han Y, Ye A, Bi L, et al. Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia. Cancer Sci. 2014;105:933–942.
   PubMed Web of Science ®Google Scholar
• Rakha EA, Boyce RW, Abd El-Rehim D, et al. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol. 2005;18:1295–1304.
   PubMed Web of Science ®Google Scholar
• Shibahara H, Tamada S, Higashi M, et al. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology. 2004;39:220–229.
   PubMed Web of Science ®Google Scholar
• Shanmugam C, Jhala NC, Katkoori VR, et al. Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer. 2010;116:3577–3586.
   PubMed Web of Science ®Google Scholar
• Matull WR, Andreola F, Loh A, et al. MUC4 and MUC5AC are highly specific tumor-associated mucins in biliary tract cancer. Br J Cancer. 2008;98:1675–1681.
   PubMed Web of Science ®Google Scholar
• Workman HC, Sweeney C, Carraway KL. The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms. Cancer Res. 2009;69:2845–2852.
   PubMed Web of Science ®Google Scholar
• Skrypek N, Duchene B, Hebbar M, et al. The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family. Oncogene. 2013;32:1714–1723.
   PubMed Web of Science ®Google Scholar
• Ponnusamy MP, Singh AP, Jain M, et al. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells. Br J Cancer. 2008;99:520–526.
   PubMed Web of Science ®Google Scholar